Skip to main content

Year: 2021

Bolt Metals Announces Conditional Sale of Cyclops Project

VANCOUVER, British Columbia, Dec. 23, 2021 (GLOBE NEWSWIRE) — Bolt Metals Corp. (“Bolt” or the “Company”) (CSE: BOLT) (FRANKFURT: A2QEUB) (OTCQB: PCRCF) is pleased to announce it has entered into a conditional share sale and purchase agreement (the “Agreement”), pursuant to which Nickel Mines Limited (ASX:NIC) (“Nickel Mines”) has agreed to acquire 100% of the Company’s interest in the Cyclops nickel-cobalt project (the “Transaction”). Pursuant to the Agreement and subject to approval of the Transaction by the shareholders of Bolt, Bolt and its subsidiaries will receive cash payments in the aggregate amount of US$6,020,000 in exchange for the Company’s 65% interest in the Cyclops project, a 5,000 hectare nickel-cobalt project located in Papua province, Indonesia (the “Cyclops Project”). If the shareholders of the Company do not...

Continue reading

UFP Technologies Acquires DAS Medical

NEWBURYPORT, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) — UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of DAS Medical, Inc. Founded in 2010 and headquartered in Atlanta, Georgia, with manufacturing in the Dominican Republic, DAS is a medical device contract manufacturer specializing in the design, development and production of single-use surgical equipment covers, robotic draping systems and fluid control pouches. “Adding DAS Medical to the UFP MedTech portfolio is another important step in our growth strategy,” said R. Jeffrey Bailly, chairman, CEO, and president of UFP Technologies. “DAS’s expertise in thin film converting and near-shore manufacturing is a perfect complement...

Continue reading

Vanguard Announces Final Cash Distributions for the Vanguard ETFs

(VBU, VBG and VGAB) TORONTO, Dec. 23, 2021 (GLOBE NEWSWIRE) — Vanguard Investments Canada Inc. today announced the final December 2021 cash distributions for certain Vanguard ETFs, listed below, that trade on Toronto Stock Exchange (TSX). Unitholders of record on December 24, 2021 will receive cash distributions payable on January 5, 2022. Please be advised that the distributions announced in this press release replace those stated in the December 17, 2021 press release for these funds. Details of the “per unit” distribution amounts are as follows:  Vanguard ETF® TSX Ticker Symbol Distribution per Unit ($) CUSIP ISIN Payment FrequencyVanguard U.S. Aggregate Bond Index ETF (CAD-hedged) VBU 0.063348 92206G103 CA92206G1037 MonthlyVanguard Global ex-U.S. Aggregate Bond Index ETF (CAD-hedged) VBG 0.652328 92206H101 CA92206H1010 MonthlyVanguard...

Continue reading

Fancamp Announces Investment in the Rare Earth Elements company NeoTerrex Corporation

VANCOUVER, British Columbia, Dec. 23, 2021 (GLOBE NEWSWIRE) — Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) is pleased to announce that it has entered into a subscription agreement (the “Agreement”) with NeoTerrex Corporation (“NeoTerrex”) as part of an oversubscribed brokered private placement of 46,844,000 common shares (the Common Shares) at a price of $ 0.10 per share and 5,600,000 flow through shares at a price of $ 0.125 in the share capital of NeoTerrex (the “Offering”). Pursuant to the Agreement, the Corporation has subscribed to 8,932,000 Common Shares at a price of $0.10 of NeoTerrex, representing approximatively 15% of the issued and outstanding shares of NeoTerrex after completion of the Offering. Concurrently with the Agreement, the Corporation also entered into an investor rights...

Continue reading

ToughBuilt Industries Launches New Quick Workbench Product Line Globally

Available to ToughBuilt’s Strategic Global Partners Servicing over 14,400 StoresToughBuilt WorkbenchToughBuilt WorkbenchLAKE FOREST, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt”) (NASDAQ: TBLT; TBLTW), announced today that it has launched a new product line, the ToughBuilt Workbench, which is now available for purchase across its strategic global partners and buying groups servicing over 14,400 stores globally. ToughBuilt’s CEO, Michael Panosian, commented on the new product line, “The launch of our new workbench brings our number of global product lines to 11, which is the result of our team’s commitment to execution.” Panosian continued, “This latest product showcases ToughBuilt’s ability to deliver unmatched versatility and durability to everyday jobsites and...

Continue reading

Milestone Scientific Names Andau Medical as an Additional Distributor for the STA Single Tooth Anesthesia System® in North America

ROSELAND, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced it has entered into an agreement with Andau Medical to distribute the STA Single Tooth Anesthesia System® in the United States and Canada. Arjan Haverhals, CEO of Milestone Scientific, stated, “We are pleased to announce the addition of Andau Medical to our growing roster of distributors for the STA Single Tooth Anesthesia System in the United States and Canada. We initially began our collaboration with Andau around our CompuFlo® Epidural Instrument in Canada. In addition to medical devices, they have a strong track record introducing dental instruments to the market, which we believe will help further fuel the strong...

Continue reading

TOMI Environmental Solutions Announces Initiation of Equity Analyst Coverage by H.C. Wainwright with a “Buy” Recommendation

FREDERICK, Md., Dec. 23, 2021 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced that H.C. Wainwright has initiated analyst coverage of the Company’s common stock. All reports on TOMI prepared by analysts represent the views of those analysts and are not necessarily those of TOMI. TOMI is not responsible for the content, accuracy, or timelines provided by analysts. A copy of the 31-page analyst report can be obtained directly from the bank. By referring to these analysts or distributing their opinions, TOMI does not in any way commit itself to the validity of such information, conclusions or recommendations. TOMI™...

Continue reading

Independent Proxy Advisory Firms ISS and Glass Lewis Recommend that Calibre Shareholders Vote “FOR” the Proposed Transaction with Fiore Gold Ltd.

For any questions please contact Calibre’s strategic shareholder advisor and proxy solicitation agent, Laurel Hill Advisory Group, toll free at 1-877-452-7184 (+1-416-304-0211 outside North America) or email assistance@laurelhill.com The deadline to vote your Calibre Shares (as defined below) at the Meeting (as defined below) is December 31, 2021 at 10:00 am (Vancouver Time)VANCOUVER, British Columbia, Dec. 23, 2021 (GLOBE NEWSWIRE) — Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (“Calibre” or the “Company”) is pleased to announce that leading independent proxy advisory firms, Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis & Co. (“Glass Lewis”) have each recommended Calibre shareholders (“Calibre Shareholders”) vote “FOR” the resolution (the “Share Issuance Resolution”) approving the issuance of common...

Continue reading

Radius Announces Update on TYMLOS® (abaloparatide) Label

FDA approved the removal of the boxed warning from the TYMLOS label, effective December 22, 2021 The boxed warning had referred to the potential risk of osteosarcoma Action follows review of long-term post-marketing data for TYMLOS and PTH class of drugsBOSTON, Dec. 23, 2021 (GLOBE NEWSWIRE) — Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS) today announced that the U.S. Food and Drug Administration (FDA) has approved updates to the TYMLOS label, including the removal of the boxed warning regarding the risk of osteosarcoma. The removal of the boxed warning comes after a thorough regulatory review of long-term post-marketing data in TYMLOS and the parathyroid hormone (PTH) class of drugs. Additional labeling revisions include updates to the Warnings and Precautions section about the risk of osteosarcoma (see Important...

Continue reading

Global Technologies, Ltd. to Spin-Off its Wholly Owned Subsidiary, Markets on Main, LLC, to Shareholders in a Stock Dividend

ST. PETERSBURG, Fla., Dec. 23, 2021 (GLOBE NEWSWIRE) — Global Technologies, Ltd. (OTC Pink: GTLL) (the “Company”), a holding corporation, which, through its subsidiaries, has operations engaged in the online sales of CBD and hemp-related products, the acquisition of intellectual property in the safety and security space, and as a portal for entrepreneurs to provide immediate access to live shopping, e-commerce, distribution and logistics, is pleased to announce that the Company will spin-off its wholly owned subsidiary, Markets on Main, LLC to shareholders. On December 17, 2021, the Company’s Board of Directors approved a corporate action to file a Notice of Conversion with the State of Florida for its wholly-owned subsidiary (the “Subsidiary”), Markets on Main, LLC, which will convert the Subsidiary from a limited liability...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.